Epidemiological profile of patients with cutaneous melanoma in a city in southern Santa Catarina
DOI:
https://doi.org/10.18593/evid.30161Keywords:
Melanoma, Skin Neoplasms, Staging of Neoplasms, EpidemiologyAbstract
Cutaneous malignant melanoma (CMM) is a skin neoplasm with increasing incidence in the recent decades, and Santa Catarina is the state with the highest incidence in the entire country. Objective: To evaluate the location, size and depth of CMM lesions in a pathology reference laboratory in southern Santa Catarina between 2007 and 2017. Methodology: A retrospective cross-sectional documentary study was carried out, consisting of the anatomopathological reports of patients whose skin biopsies were sent to the laboratory studied in the period between 2007 and 2017. Patients whose report confirmed the diagnosis of cutaneous malignant melanoma in the period between 2007 and 2017 were included. Results: We analyzed 232 cases of CCM. The highest prevalence occurred in the 50 to 69 age group. There was a linear increase in the number of occurrences in the period studied. A statistically significant association was found between the Breslow index, the presence of ulceration and the number of tumor mitoses (p<0.001). Conclusion: The data found showed a significant association between the Breslow index, the presence of ulceration and the number of tumor mitoses.
Downloads
References
Hall BJ, et al. Sauer‘s Manual of Skin Diseases. 10th rev. ed. Filadélfia, PA: Lippincott Williams & Wilkins; 2010;313-16. ISBN: 13: 978-1-60547-077-1. E-book.
Battisti R, Weber AL, Sgrott I, Nunes DH, Schweitzer LC. Avaliação do perfil epidemiológico e da mortalidade dos pacientes com diagnóstico de melanoma cutâneo primário no município de Florianópolis. Anais Brasileiros de Dermatologia. 2020;84:335-42. DOI: https://doi.org/10.1590/S0365-05962009000400003
Ministério da Saúde. Secretaria de Atenção à Saúde. Portaria nº 357. Aprova as Diretrizes Diagnósticas e Terapêuticas do Melanoma Maligno Cutâneo; 2013.
Instituto Nacional do Câncer. Tipos de Câncer. Câncer de pele melanoma; 2020.
Moreno M, Conte B, Menegat E. Diferenças Clínico-Epidemiológicas entre Pacientes Masculinos e Femininos com Diagnóstico de Melanoma Cutâneo no Oeste de Santa Catarina. Revista Brasileira de Cancerologia. 2015;61:15-21. DOI: https://doi.org/10.32635/2176-9745.RBC.2015v61n1.357
Sociedade Brasileira de Dermatologia. Câncer da pele; 2017.
Moreno M, Ciotta CM, Vedana GC, Miranda MHF. Risk factors for developing cutaneous melanoma in Santa Catarina, Brazil: a case-control observational study. Journal of Dermatology & Cosmetology. 2017;1(1):10-14. DOI: https://doi.org/10.15406/jdc.2017.01.00004
World Health Organization. Estimated number of new cases in 2018, worldwide, both sexes, all ages; 2018.
Instituto Nacional do Câncer. Estimativa 2020; 2019.
Bakos L, et al. European ancestry and cutaneous melanoma in Southern Brazil. Journal of the European Academy of Dermatology and Venereology. 2009;23:304-07. DOI: https://doi.org/10.1111/j.1468-3083.2008.03027.x
Sociedade Brasileira de Dermatologia. Análise de dados das campanhas de prevenção de câncer de pele promovidas pela Sociedade Brasileira de Dermatologia de 1999 a 2005. Anais Brasileiros de Dermatologia. 2006;81:533-39. DOI: https://doi.org/10.1590/S0365-05962006000600004
Flores DA, et al. Perfil epidemiológico da mortalidade por melanoma cutâneo no Estado de Santa Catarina entre 2005 e 2017. UFFS – Universidade Federal da Fronteira Sul; 2019.
Instituto Brasileiro de Geografia e Estatística. Diretoria de Pesquisas, Coordenação de População e Indicadores Sociais; 2020. Cidades e Estados: Tubarão; 2020.
de Souza VPD, Unfried AAC. Análise dos dados epidemiológicos e histopatológicos dos laudos anatomopatológicos de melanoma cutâneo diagnosticados no município de Criciúma/SC. Criciúma: Faculdade de Medicina, Universidade do Extremo Sul Catarinense; 2015. 17 p.
Lima AS, Casemiro KP, Stein CE, Rovere RK. Epidemiology of Melanoma in the South of Brazil: study of a city in the Vale doItajaí from 1999 to 2013. Anais Brasileiros de Dermatologia. 2015;90:185-9. DOI: https://doi.org/10.1590/abd1806-4841.20153076
Brandão FV, Gontijo B, Pereira AFJR, Bittencourt FV. Epidemiological aspects of melanoma at a university hospital dermatology center over a period of 20 years. Anais Brasileiros de Dermatologia. 2013;88:344-353. DOI: https://doi.org/10.1590/abd1806-4841.20131855
Foiato TF, et al. Analysis of patients diagnosed with primary cutaneous melanoma in the last six years in Hospital Erasto Gaertner: epidemiological profile. Anais Brasileiros de Dermatologia. 2018;93:332-36. DOI: https://doi.org/10.1590/abd1806-4841.20185788
Steglich RB, Cardoso S, Gaertner MHCN, Coelho KMPA, Cestari TF, Franco SC. Differences in the diagnosis of primary cutaneous melanoma in the public and private healthcare systems in Joinville, Santa Catarina State, Brazil. Anais Brasileiros de Dermatologia. 2018;93:507-512. DOI: https://doi.org/10.1590/abd1806-4841.20185767
Azzola MF, et al. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma. American Cancer Society. 2003;97:1488-498. DOI: https://doi.org/10.1002/cncr.11196
Namikawa K, et al. Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center. Cancer Medicine. 2018;7:583-593. DOI: https://doi.org/10.1002/cam4.1320
Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. Journal of Clinical Oncology. 2009;27:6199-206. DOI: https://doi.org/10.1200/JCO.2009.23.4799
Balch CM, Wilkerson JA, Murad TM, Soong SJ, Ingalls AL, Maddox WA. The prognostic significance of ulceration in cutaneous melanoma. Cancer. 1980;45(12):3012-17. DOI: https://doi.org/10.1002/1097-0142(19800615)45:12<3012::AID-CNCR2820451223>3.0.CO;2-O
Tas F, Erturk K. Primary tumour ulceration in cutaneous melanoma: its role on TNM stages. Japanese Journal of Clinical Oncology. 2021;51(2):192-198. DOI: https://doi.org/10.1093/jjco/hyaa191
Mays MP, et al. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy? Cancer. 2010;116:1535-1544. DOI: https://doi.org/10.1002/cncr.24895
Castro LGM, Bakos RM, Duprat JP, Bittencourt FV, Di Giacomo THB, Serpa SS, et al. Brazilian Guidelines for diagnosis, treatment and follow-up of primary cutaneous melanoma – Part II. Anais Brasileiros de Dermatologia. 2016;91(1):49-58. DOI: https://doi.org/10.1590/abd1806-4841.20164715
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Evidence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright Statement
The authors retain the copyrights and grant the Journal the right of the first publication, with the work being simultaneously licensed by a Creative Commons - Attribution - Non-Commercial 4.0 International License.
